TT Electronics Facility Receives FDA Registration in USA


Reading time ( words)

TT Electronics, a global provider of engineered electronics for performance critical applications, announced that the U.S. Federal Drug Administration (FDA) has confirmed registration for its Cleveland, Ohio manufacturing facility. The registration allows the company to manufacture finished medical instruments and devices, like imaging and diagnostic systems, in the USA.

As an FDA registered establishment, the facility is now recognised under the stringent standards of the FDA, reinforcing the company’s commitment to providing the most comprehensive range of services to its global customers. 

The registration follows TT’s earlier announcement of its new, advanced manufacturing facility in Asia which allows the company to further broaden its capabilities in direct response to demand from life science customers.

“This is an important step in our healthcare industry growth strategy. Our FDA designation will provide a significant advantage in supporting our current customers, many of whom are global leaders in their fields,” said TT Electronics EVP, Michael Leahan. “TT has been supporting medical and life science technology innovators for over a decade. Our customers can now leverage our expanded capabilities in the USA to manufacture and deliver finished, complex medical products – with the same world class service experience that they’ve come to expect from TT.” 

Manufacturing facilities that are involved in the production and distribution of medical devices intended for use in the United States are required to register annually with the FDA. This registration provides the FDA with the location of medical device establishments and the devices manufactured at those establishments. Knowing where devices are made increases the nation’s ability to prepare for and respond to public health emergencies.

Share




Suggested Items

Four Silver Linings in the Stormy Clouds of Pandemic, Supply Chain, and Inflation

09/14/2022 | Dr. Ronald C. Lasky, Indium Corp.
It may be difficult to see any bright spots in the current and recent economic situation. We have all experienced the devastation of the pandemic, supply chain issues, and most recently, inflation. However, as a senior technologist for an international materials supplier (Indium Corporation) and a professor of engineering at an Ivy League research university (Dartmouth College), I offer these four silver linings for those of us in the electronics industry.

Thriving Through Greater EMS Collaboration

08/23/2022 | Chris Peters, USPAE
Events of the past two years have clearly demonstrated the value of strong trading relationships. When materials become constrained, as in the recent microchip shortage or any of the pandemic-driven supply chain snafus, the companies that have those materials have a choice to make. Which customers will be put at the front of the line, and which will be placed at the rear? Too often, company executives assume that since they are a large buyer, they automatically will be prioritized when supplies are constrained. Research has shown that this is not always the case, and that assumption can leave a company in a weakened position.

New Book from I-Connect007 Examines Evolution of Electronics Industry NPI

08/01/2022 | I-Connect007
The Electronics Industry’s Guide to… The Evolving PCB NPI Process is the first book in I-Connect007’s new The Electronics Industry’s Guide to… technical series. This valuable resource is for all segments of the electronics interconnect industry.



Copyright © 2022 I-Connect007. All rights reserved.